Odyssey Health (ODYY) FCF Margin (2014 - 2016)

Odyssey Health (ODYY) reported FCF Margin of 63.13% for Q3 2016, up 31.13% sequentially from 91.66% in Q2 2016.

Odyssey Health (ODYY) FCF Margin (2014 - 2016) Analysis & Trends

Odyssey Health has disclosed FCF Margin across 3 years of filings, most recently posting 63.13% for Q3 2016.

  • Quarterly FCF Margin changed N/A year-over-year to 63.13% in Q3 2016, while the trailing twelve-month figure through Apr 2017 was 594.98% (down 36233.0% YoY) and the FY2016 annual result came in at 171.34%, down 24358.0% from the prior year.
  • FCF Margin rose to 63.13% in Q3 2016, from 91.66% in the prior quarter.
  • Across five years, FCF Margin topped out at 87.73% in Q4 2014 and bottomed at 91.66% in Q2 2016.
  • The 3-year median for FCF Margin is 26.77% (2015), against an average of 3.95%.
  • The widest YoY moves for FCF Margin: up 11843 bps in 2016, down 11843 bps in 2016.
  • Odyssey Health's FCF Margin stood at 87.73% in 2014, then plunged by 69 bps to 26.77% in 2015, then plunged by 336 bps to 63.13% in 2016.
  • According to Business Quant data, FCF Margin over the past three periods registered 63.13%, 91.66%, and 26.77% for Q3 2016, Q2 2016, and Q2 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 8.20%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 6.89%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 25.51%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 3.29%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -1.28%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.68%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 37.67%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 3.98%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 15.44%
10 Odyssey Health - - - -

Historic Data

Download Data
DateValue
Jul 31, 2016 -63.13%
Apr 30, 2016 -91.66%
Apr 30, 2015 26.77%
Jan 31, 2015 60.06%
Oct 31, 2014 87.73%